BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today welcomes investors, analysts and financial media to the company's Capital Markets Day.

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Healthy returns: Japan’s assault on old-age di ...

Biogen and City Therapeutics are to partner for the development of new RNA interference (RNAi) therapies. Leveraging ...

Nuravax and others are working on the next wave of Alzheimer’s treatments to catch the disease before symptoms arise.